A study investigating the effect of CYP2C19 polymorphism on the therapeutic efficacy in patients with eosinophilic esophagitis
Not Applicable
- Conditions
- Eosinophilic esophagitis
- Registration Number
- JPRN-UMIN000026704
- Lead Sponsor
- Shimane University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are not treated by proton pump inhibitor or those who are not scheduled to treat by proton pump inhibitor 2) Patients who are judged inadequate for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method